scholarly journals ISYDE-Ψ* First step of the implementation of guidelines for psychology activities in cardiac rehabilitation and prevention *Italian SurveY on CarDiac REhabilitation – Psychology

2005 ◽  
Vol 64 (1) ◽  
Author(s):  
Marinella Sommaruga ◽  
Roberto Tramarin ◽  
Gianluigi Balestroni ◽  
Ornella Bettinardi ◽  
Maria Antonella Cauteruccio ◽  
...  
Keyword(s):  
Cardiac Rehabilitation ◽  
Task Force ◽  
National Guidelines ◽  
Rehabilitation Psychology ◽  
Training Project ◽  
Training Requirements ◽  
Italian Survey ◽  
Interactive Training ◽  
Rehabilitation Facilities ◽  
Correct Application

The Italian SurveY on CarDiac REhabilitation – Psychology (ISYDE-Ψ) was developed, in line with the indications of the Italian National Guidelines Program, as part of a project to implement and apply the guidelines for psychology interventions in cardiac rehabilitation and prevention published in 2003. The Task Force on Psychological Interventions in Cardiac Rehabilitation conducted this pilot survey of the existing situation of Psychology in order to prepare the ground for implementation of the guidelines through interactive training. As part of the evaluation of training requirements a questionnaire was elaborated to gather information on the models of organization of and activities carried out by psychologists working in the surveyed cardiac rehabilitation facilities. Data collection for ISYDE-Ψ terminated at the end of March 2005, with replies from 68/107 (63.6%) structures. In the light of this response, the Task Force has developed a training project for psychologists working in cardiac rehabilitation, sponsored by the Italian Council of Psychologists, that will be implemented in different regions of the country with the aim of disseminating the guidelines and promoting their correct application despite the existing regional disparities in organization.

Cardiac rehabilitation and exercise training

ESC CardioMed ◽  
2018 ◽  
pp. 882-892
Author(s):  
Alessandro Mezzani ◽  
Stephan Gielen
Keyword(s):  
Cardiovascular Disease ◽  
Exercise Training ◽  
Cardiac Rehabilitation ◽  
National Guidelines ◽  
Risk Factor Modification ◽  
The Core ◽  
Prevention Programmes ◽  
Core Components ◽  
Guidelines And Standards ◽  
Factor Modification

Secondary prevention programmes are delivered as cardiac rehabilitation or other prevention programmes for all patients with cardiovascular disease or at high risk for cardiovascular disease. Cardiac rehabilitation is defined as a comprehensive programme involving exercise training, risk factor modification, education, and psychological support. The core components and goals of cardiac rehabilitation have been standardized, but the structure, length, and type of programme offered differs widely by country, affected by national guidelines and standards, legislation, and payment factors.

scholarly journals Quantifying the impact of delayed delivery of cardiac rehabilitation on patients’ health

2020 ◽  
Vol 27 (16) ◽  
pp. 1775-1781
Author(s):  
Sebastian Hinde ◽  
Alexander Harrison ◽  
Laura Bojke ◽  
Patrick Doherty
Keyword(s):  
National Health Service ◽  
Health Service ◽  
Life Expectancy ◽  
Cardiac Rehabilitation ◽  
National Health ◽  
Average Lifetime ◽  
National Guidelines ◽  
Patient Health ◽  
The Impact

Background Despite its role as an effective intervention to improve the long-term health of patients with cardiovascular disease and existence of national guidelines on timeliness, many health services still fail to offer cardiac rehabilitation in a timely manner after referral. The impact of this failure on patient health and the additional burden on healthcare providers in an English setting is quantified in this article. Methods Two logistic regressions are conducted, using the British Heart Foundation National Audit of Cardiac Rehabilitation dataset, to estimate the impact of delayed cardiac rehabilitation initiation on the level of uptake and completion. The results of these regressions are applied to a decision model to estimate the long-term implications of these factors on patient health and National Health Service expenditure. Results We demonstrate that the failure of 43.6% of patients in England to start cardiac rehabilitation within the recommended timeframe results in a 15.3% reduction in uptake, and 7.4% in completion. These combine to cause an average lifetime loss of 0.08 years of life expectancy per person. Scaled up to an annual cohort this implies 10,753 patients not taking up cardiac rehabilitation due to the delay, equating to a loss of 3936 years of life expectancy. We estimate that an additional £12.3 million of National Health Service funding could be invested to alleviate the current delay. Conclusions The current delay in many patients starting cardiac rehabilitation is causing quantifiable and avoidable harm to their long-term health; policy and research must now look at both supply and demand solutions in tackling this issue.

High prevalence of physical inactivity after heart valve surgery and its association with long-term mortality: A nationwide cohort study

2020 ◽  
pp. 204748732090387 ◽  
Author(s):  
Sun-Hyung Kim ◽  
Seungwoo Cha ◽  
Seongmin Kang ◽  
Kyungdo Han ◽  
Nam-Jong Paik ◽  
...  
Keyword(s):  
Cardiac Rehabilitation ◽  
Heart Valve ◽  
Valve Surgery ◽  
Active Group ◽  
Heart Valve Surgery ◽  
National Guidelines ◽  
Risk Of Mortality ◽  
Before And After ◽  
Inactive Group

Aims Physical activity (PA) and systematic efforts, such as cardiac rehabilitation, are recommended by several national guidelines for those who have received heart valve surgery. However, only a few studies have demonstrated real-world situations, such as changes in the PA level after heart valve surgery, and their effects on long-term outcomes. We designed this study to investigate the changes in PA after heart valve surgery and their associations with mortality using nationwide representative data. Methods This study was performed using the Korean National Health Insurance Service database. We included patients who received heart valve surgery from 2009 to 2015 and underwent regular health checkups before and after surgery. Subjects were grouped according to their PA level before and after the surgery. Information on all-cause mortality was obtained until 31 December 2016, with a maximum follow-up period of 5 years. Results Of the 6587 subjects, 3258 (49.5%) were physically inactive after surgery. Among patients who were physically active ( n = 3070), 1196 (39.0%) became inactive after surgery. The postoperative ‘inactive’ group showed higher mortality than the ‘active’ group (hazard ratio (HR): 1.41, 95% confidence interval (CI): 1.08–1.83). The ‘inactive/inactive’ group showed the highest risk of mortality (HR: 1.69, 95% CI: 1.19–2.40) compared with the ‘active/active’ group. Conclusions Insufficient PA level after heart valve surgery is associated with higher risk of mortality. However, maintaining sufficient PA after heart valve surgery may be challenging for many patients. Therefore, systematic efforts, such as cardiac rehabilitation, should be considered in those who received heart valve surgery.

Development and implementation of an evidence-based malignant hematology clinical pathway program.

2020 ◽  
Vol 38 (29_suppl) ◽  
pp. 304-304
Author(s):  
Amanda Brahim ◽  
Fernando Manuel Vargas Madueno ◽  
Robert Wilkinson ◽  
Melissa Hardwick ◽  
Yehuda Ethan Deutsch ◽  
...  
Keyword(s):  
Supportive Care ◽  
Task Force ◽  
Clinical Pathways ◽  
Tumor Lysis Syndrome ◽  
Comprehensive Cancer Center ◽  
Cancer Center ◽  
Evidence Based ◽  
National Guidelines ◽  
Bone Marrow Biopsies ◽  
Treatment Plans

304 Background: Clinical pathways provide a means to maximize value-based care for cancer patients. They have been associated with decreased costs and outcome improvements. Our institution entered a transformative partnership with an NCI designated comprehensive cancer center for the treatment of hematologic malignancies. As part of the collaboration, a multidisciplinary task force was established to adapt clinical pathways within our system. Given the multiple new drug approvals for the treatment of Acute Myeloid Leukemia (AML), this was the first pathway created. Methods: The taskforce consisted of physicians, pharmacists, nurses, quality manager, and information technology staff. The group met weekly to draft algorithms in accordance with national guidelines, updated evidence and institutional preferences. Electronic Medical Record (EMR) treatment plans were reviewed in a secondary multidisciplinary workgroup and validated to ensure compliance with the AML pathway. When applicable, specific criteria for use were developed to aid in medication use optimization. The finalized pathway and treatment plans were presented and approved at our clinical standards committee meeting. A chart audit was performed one year after pathway implementation to assess adherence, with a goal of 80% or higher. The results were compared to an audit assessing adherence to best available clinical evidence for the year prior to implementation. Results: The group established a consensus on treatment, laboratory testing, and supportive care, including anti-emetic, anti-microbial, and tumor lysis syndrome (TLS) prophylaxis. Electronic order sets were created for bone marrow biopsies, transfusion support, TLS and febrile neutropenia. Thirty-two EMR treatment plans for AML were built and/or revised, while five were inactivated. A total of 88 patient charts were included in the pathway adherence audit (44 before and 44 after implementation). Pre and post pathway adherence was 64% and 89%, respectively (p=0.006). Deviations were categorized by type (table). Conclusions: AML pathway development and implementation resulted in standardization of treatment regimens, supportive care and higher adherence to institutional evidence based practices. [Table: see text]

Appreciation for the Role and Hiring Trends of Exercise Physiologists in Regional Cardiac Rehabilitation Facilities

2016 ◽  
Vol 48 ◽  
pp. 658
Author(s):  
Allison Bowersock ◽  
Alex Breeding ◽  
Alex Sheppard
Keyword(s):  
Cardiac Rehabilitation ◽  
Rehabilitation Facilities

scholarly journals Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice

2010 ◽  
Vol 69 (11) ◽  
pp. 1913-1919 ◽  
Author(s):  
M C van der Goes ◽  
J W G Jacobs ◽  
M Boers ◽  
T Andrews ◽  
M A M Blom-Bakkers ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Adverse Events ◽  
Low Dose ◽  
Task Force ◽  
Fasting Blood Glucose ◽  
Daily Practice ◽  
Therapeutic Effects ◽  
Who Guidelines ◽  
National Guidelines ◽  
Eular Recommendations

ObjectiveTo develop recommendations on monitoring for adverse events (AEs) of low-dose glucocorticoid (GC) therapy (≤7.5 mg prednisone or equivalent daily) in clinical trials and daily practice.MethodsLiterature was searched for articles containing information on incidence and monitoring of GC-related AEs using PubMed, EMBASE and Cochrane databases. Second, the authors searched for broad accepted guidelines on the monitoring of certain AEs (eg, WHO guidelines on screening for diabetes). Available data were summarised and discussed among experts (rheumatologists and patients) of the EULAR Task Force to decide which potential AEs should be monitored, how and at which interval.ResultsData on monitoring proved to be scarce; most articles were focused on therapeutic effects of GCs, not on occurrence and monitoring of AEs. Most recommendations had to be based on consensus. Those for clinical trials aimed at getting insights into incidence, prevalence and clinical relevance of AEs to create a comprehensive and valid AE-profile of GC therapy. The set of AEs to monitor is therefore more extensive, and often consists of assessments at baseline and at end of trials. Recommendations for daily practice are meant to protect patients from real dangers, which can be prevented or treated. Standard care monitoring needs NOT be extended for patients on low-dose GC therapy, except for osteoporosis (follow national guidelines), and baseline assessments of ankle edema, fasting blood glucose and risk factors for glaucoma.ConclusionGiven the incompleteness of literature data, consensus-based recommendations on monitoring for GC-related AEs were created, separately for daily practice and clinical trials.

Sign in / Sign up

Export Citation Format

Share Document